Compare INAB & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INAB | SOAR |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 12.3M |
| IPO Year | 2020 | 2021 |
| Metric | INAB | SOAR |
|---|---|---|
| Price | $0.75 | $0.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 69.2K | ★ 1.5M |
| Earning Date | 11-05-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 104.83 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $0.10 |
| 52 Week High | $2.73 | $1.40 |
| Indicator | INAB | SOAR |
|---|---|---|
| Relative Strength Index (RSI) | 32.88 | 42.55 |
| Support Level | N/A | $0.18 |
| Resistance Level | $1.50 | $0.19 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.62 | 25.07 |
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
SOAR AI Inc is an AI infrastructure and software company focused on the development and operation of AI infrastructure and AI-powered software solutions. The company is actively constructing an AI infrastructure campus in Ohio that combines data center infrastructure, high-density GPU compute, high-performance networking and related technology to support AI, machine learning and high-performance computing workloads. It also develops AI-powered operational systems for aviation businesses through its Aviation AI platform and operates Vaunt, a technology-enabled private aviation membership platform.